INTRODUCTION
Acute respiratory failure (ARF) is a complication in surgical patients, especially after abdominal surgery. ARF after abdominal surgery is closely associated with a reduction in lung volume caused by alveolar collapse and dysfunction of the diaphragm, increased intraabdominal pressure after surgery, and decreased respiration caused by pain [1] [2] [3] [4] . Treatment of post-operative ARF usually includes endotracheal tube insertion and mechanical ventilation.
More recently, however, patients with post-operative ARF have been treated by non-invasive ventilation (NIV) [5] , consisting of attachment of a mask to the face without endotracheal tube insertion ( Fig. 1) , followed by deliveries of positive air pressure by pressure support ventilation (PSV) and positive end expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) [6, 7] . NIV with positive pressure ventilation can relieve a patient's inspiratory efforts and improve gas exchange without the caused by the use of sedatives [6] .
NIV was initially applied to treat patients with chronic obstructive pulmonary disease. In addition to successfully treating ARF, NIV reduced invasive intubation and mortality rates, and shortened treatment periods [8] [9] [10] . NIV has been utilized primarily to treat patients with hypercarbic respiratory failure, and its therapeutic role in treating psychogenic ARF and ARF after abdominal or thoracic surgery is expanding [11] [12] [13] [14] [15] . We therefore assessed the usefulness of NIV in surgical patients with ARF.
METHODS
We retrospectively reviewed the medical records of the 
RESULTS

Classification of patient groups according to underlying diseases
We identified 74 patients who were treated in the surgi-thesurgery.or.kr Values are presented as mean ± SD or number (%). APACHE, acute physiology and chronic health evaluation; ICU, intensive care unit. 
Comparison of invasive ventilation and NIV patient groups
Of the 74 ARF patients, 59 patients (79.7%) received invasive ventilation, and 15 (20.3%) received NIV ( Their mean APACHE II score was 14 ± 6 points, and their mean PaO2/FiO2 was 115 ± 71 points.
The mean duration of artificial respirator application in the invasive ventilation group was 13.9 ± 18.0 days, their mean stay in the intensive care unit was 17.6 ± 19.6 days, and 13 of these 59 patients (22.0%) died. In comparison, the mean duration of artificial respirator application in the NIV group was 6.0 ± 6.0 days, their mean stay in the intensive care unit was 9.4 ± 7.6 days, and 2 of these 15 patients (13.3%) died.
Although the mean days of mechanical ventilation and stay in the intensive care unit differed in the two group, these differences were not statistically significant (P = 0.62 and 0.58 respectively). This may have been due to the severity of illness in several patients who received invasive ventilation requiring treatment for a long time.
Conversion from NIV to invasive ventilation
Among the 15 patients in the NIV group, 10 (66.7%)
were treated successfully without endotracheal intubation, whereas 5 (33.3%) were converted to invasive ven- tilation during treatment. The causes of conversion included patient noncooperation in 2 patients, the deterioration of hypercapnea in 1, deterioration of hypoxia in 1, and dyspnea symptoms in 1 (Table 3) . Causative diseases in these 5 patients included atelectasis in 2, pneumonia in 2 and psychogenic pulmonary edema in 1. The mean time to conversion in these 5 patients was 28.2 hours after the start of NIV. Particularly, in patients whose causative disease was pneumonia, there was a trend toward a longer treatment period even after the conversion to invasive ventilation.
Application of NIV to ARF patients after extubation
Of the 59 patients who received invasive ventilation, 3
were treated by NIV for respiratory failure after extubation, thus avoiding re-intubation (Table 4) . Respiratory failure after extubation was defined as development of dyspnea symptoms within 12 hours after weaning. Of these 3 patients, 2 had post-operative atelectasis and 1 had acute lung injury due to multiple trauma. All were treated successfully by NIV without re-intubation.
Factors predictive of the success of NIV
NIV was successful in 10 of 15 patients. Univariate and multivariate analysis showed that success was related to the etiology of ARF, especially atelectasis (P = 0.032). NIV was more likely to be successful in patients with postoperative atelectasis, whereas invasive ventilation was more likely to be successful in patients with pneumonia. In contrast, patient age, gender, treatment with or immune suppressors, and the severity of respiratory function were not predictive of success (Table 2) .
DISCUSSION
We have shown here that surgical patients with ARF can be treated effectively with NIV. The likelihood of NIV success is determined by the disease causing ARF not by the severity at the time of ARF or level of hypoxia. In particular, NIV was more likely to be successful in patients with postoperative atelectasis, whereas invasive ventilation was more likely to be successful in patients with pneumonia.
Although, hypoxia develops in 30 to 50% of patients after surgery, it improves slowly over several weeks in most patients without symptoms. In some patients, however, hypoxia can progress to dyspnea. Impaired gas exchange can be induced by the reduction in muscle tension caused thesurgery.or.kr Of ARF patients weaned from mechanical ventilation as planned, 6 to 23% require re-intubation with 48 to 72 hours [22] [23] [24] . This is due primarily to obstruction of the upper airways, insufficient coughing or expectoration, deterioration of consciousness, or myocardial failure. Although re-intubation reflects disease severity, intubation itself is an independent factor associated with increases in rates of pneumonia and death and duration of hospitalization [23, 25] . Therefore, prevention of re-intubation is very important in the treatment of critically ill patients. In patients who developed respiratory failure after weaning, NIV was unable to lower mortality or re-intubation rate [25] .
However high risk patients who received NIV soon after extubation, without re-intubation, could be successfully weaned from mechanical ventilation with a reduced mortality rate within the intensive care unit [26] . Similarly, all 3 of our patients who developed ARF after extubation were treated successfully with NIV without re-intubation.
Due to the retrospective design of our study, we could not control for factors such as the disease causing ARF at the time of therapeutic intervention, disease severity and clinical symptoms. This study, however, is to compare NIV with invasive ventilation in surgical patients in Korea. Prospective analysis of the prophylactic and therapeutic effects of NIV are therefore required.
In conclusion, we found that NIV may be successful in surgical patients who develop ARF, particularly in selected patients with post-operative atelectasis. The severity of ARF or hypoxia at the time of intervention was not associated with the effects of NIV. Moreover, NIV can successfully prevent re-intubation in patients who devel-
